• About the webinar:

     
    Krebs von den Lungen 6 (KL-6) is a mucin-like glycoprotein expressed on the surface membrane of alveolar epithelial cells (AEC) and bronchiolar epithelial cells.

    Type II AEC are centrally involved in the pathobiology of Interstitial Lung Diseases (ILD). Serum KL-6 reflects AEC-II injury by direct leakage through the interstitium to the bloodstream.

    KL-6 is also showing evolving evidence as a valuable tool in the current COVID-19 pandemic to aid in early identification of patients at high risk of developing Acute Respiratory Distress Syndrome (ARDS) as well as assist in the evaluation of residual fibrosis as a result of acute lung injury (ALI) after COVID-19 infection.

    In this webinar Dr. Francesco Bonella (MD), Dr. Elena Bargagli (MD), Dr. Diego Castillo (MD) and Dr. Miriana d'Alessandro (PhD, Biologist) review the latest information on the role of KL-6 in the management of these critical patients.

  • KL-6 webinar
  • .

  • Objectives:
     

    • Understand the role of KL-6 in Epithelial Alveolar Damage in ILD and COVID-19.
    • Describe the utility of KL-6 in the screening and treatment monitoring of patients with CTD-ILD.
    • Application of a fully automated immunoassay in the laboratory for the routinely assessment of ILD/COVID-19.

     
    Who should attend:
     

    • Pneumologists
    • Rheumatologists
    • Laboratories
    • Intensivist (ICUs)
    • Emergency physicians
    • Pharmacists
       

    Watch the replay now 

  • About the speakers:

    Dr. Francesco Bonella

    Dr. Francesco Bonella (MD), Moderator

    Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University Hospital, Essen, Germany

    More details

    Professor Elena Bargali

    Dr Elena Bargagli (MD), Speaker

    Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, Siena University Hospital, Siena, Italy

    More details

    Dr. Diego Castillo

    Dr. Diego Castillo (MD), Speaker

    Pneumology and Allergy Service of the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    More details

    Dr. Mirianda d'Alessandro

    Dr. Miriana d'Alessandro (PhD, Biologist), Speaker

    Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, Siena University Hospital, Siena, Italy

    More details